The Scales of American Justice Keep Tilting Toward China

A federal judge’s decision this month to stop the U.S. Defense Department from blacklisting a Chinese biotech firm was the latest demonstration of the lopsided legal contest between the United States and China. The Pentagon had determined that WuXi AppTec, a major pharmaceutical contractor headquartered in Shanghai, was helping to support China’s military modernization and sought to place restrictions on the company. WuXi AppTec responded by going to an American court—and winning. The ruling was a setback for the Pentagon’s attempts to weaken China’s policy of military-civil fusion, a national strategy to allow its defense sector to capitalize on civilian…